Which has grown faster, CYTK or HQY?

Over the past five years, HQY grew revenue faster — CYTK at a 4.19% CAGR versus HQY at 12.96%.

Is CYTK or HQY more profitable?

HQY runs the higher net margin — CYTK at -1259.87% versus HQY at 17.36%.

How have CYTK and HQY total returns compared?

Over the past 10 years, CYTK delivered 20.95% and HQY delivered 9.16% annualized total return. Past performance doesn't predict future results.

Cytokinetics, Incorporated (CYTK) vs HealthEquity, Inc. (HQY)

A side-by-side comparison of Cytokinetics, Incorporated and HealthEquity, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CYTK

Cytokinetics, Incorporated

$7.71B

$61.94HealthcareDelayed quote: Oct 6, 2026, 9:45 AM EDT

HQY

HealthEquity, Inc.

$7.67B

$91.76HealthcareDelayed quote: Oct 6, 2026, 9:40 AM EDT

Total return — CYTK vs HQY

growth of $100 · dividends reinvested · last 10y

CYTK +570.6% (+21.0%/yr)HQY +141.7% (+9.2%/yr)CYTK compounded faster over this window

CYTK HQY

CYTK vs HQY: by the numbers

•CYTK is the larger company ($7.71B vs $7.67B market cap).
•HQY is profitable (17.36% net margin) while CYTK runs a net loss (-1259.87%).
•HQY grew revenue faster over the past five years (12.96% vs 4.19% CAGR).

Metrics side by side

Valuation

Metric	CYTK	HQY
P/E ratio	N/A	33.13
Forward P/E	N/A	19.43
PEG ratio	N/A	0.40
P/S ratio	108.61	5.63
P/B ratio	N/A	3.85
EV / EBITDA	N/A	17.44
FCF yield	N/A	6.15%

Profitability

Metric	CYTK	HQY
Gross margin	84.97%	75.21%
Operating margin	-695.44%	25.61%
Net margin	-1259.87%	17.36%
ROE	N/A	11.88%
ROIC	-39.80%	8.55%

Growth (annualized)

Metric	CYTK	HQY
Revenue CAGR (5Y)	4.19%	12.96%
EPS CAGR (5Y)	N/A	83.56%
FCF CAGR (5Y)	N/A	36.72%
Total return CAGR (5Y)	11.24%	7.00%

Frequently asked

Which has grown faster, CYTK or HQY?: Over the past five years, HQY grew revenue faster — CYTK at a 4.19% CAGR versus HQY at 12.96%.
Is CYTK or HQY more profitable?: HQY runs the higher net margin — CYTK at -1259.87% versus HQY at 17.36%.
How have CYTK and HQY total returns compared?: Over the past 10 years, CYTK delivered 20.95% and HQY delivered 9.16% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CYTK analysis Full HQY analysis Interactive comparison tool

Dig into the metrics

HealthEquity P/E ratio Cytokinetics ROE HealthEquity ROE Cytokinetics operating margin HealthEquity operating margin Cytokinetics revenue growth HealthEquity revenue growth Cytokinetics free cash flow HealthEquity free cash flow

Cytokinetics & HealthEquity appear in these rankings

Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.